These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 10385254

  • 1. Cyclic AMP suppresses interleukin-5 synthesis by human helper T cells via the downregulation of the calcium mobilization pathway.
    Kaminuma O, Mori A, Ogawa K, Kikkawa H, Nakata A, Ikezawa K, Okudaira H.
    Br J Pharmacol; 1999 May; 127(2):521-9. PubMed ID: 10385254
    [Abstract] [Full Text] [Related]

  • 2. Two differential effects of cyclic adenosine 3',5'-monophosphate on IL-5 production by antigen-specific human T cell line.
    Kaminuma O, Mori A, Ogawa K, Wada K, Kikkawa H, Naito K, Suko M, Okudaira H.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):345-9. PubMed ID: 9336342
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
    Chouaib S, Welte K, Mertelsmann R, Dupont B.
    J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
    [Abstract] [Full Text] [Related]

  • 4. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
    Watanabe T, Satoh H, Togoh M, Taniguchi S, Hashimoto Y, Kurokawa K.
    J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
    [Abstract] [Full Text] [Related]

  • 5. Effect of prostaglandin E2 (PGE2) on IL-3/granulocyte-macrophage colony-stimulating factor production by T helper cells. Mode of stimulation and presence of costimulation can determine response to PGE2.
    Li TK, Fox BS.
    J Immunol; 1993 Mar 01; 150(5):1680-90. PubMed ID: 8436811
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells.
    Rincón M, Tugores A, López-Rivas A, Silva A, Alonso M, De Landázuri MO, López-Botet M.
    Eur J Immunol; 1988 Nov 01; 18(11):1791-6. PubMed ID: 2849551
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-1 up-regulates transcription of its own receptor in a human fibroblast cell line TIG-1: role of endogenous PGE2 and cAMP.
    Takii T, Akahoshi T, Kato K, Hayashi H, Marunouchi T, Onozaki K.
    Eur J Immunol; 1992 May 01; 22(5):1221-7. PubMed ID: 1315688
    [Abstract] [Full Text] [Related]

  • 8. PGE2 induces IL-1beta gene expression in mouse osteoblasts through a cAMP-PKA signaling pathway.
    Park YG, Kang SK, Noh SH, Park KK, Chang YC, Lee YC, Kim CH.
    Int Immunopharmacol; 2004 Jun 01; 4(6):779-89. PubMed ID: 15135319
    [Abstract] [Full Text] [Related]

  • 9. IL-2-induced IL-9 production by allergen-specific human helper T-cell clones.
    Kajiyama Y, Umezu-Goto M, Kobayashi N, Takahashi K, Fukuchi Y, Mori A.
    Int Arch Allergy Immunol; 2007 Jun 01; 143 Suppl 1():71-5. PubMed ID: 17541281
    [Abstract] [Full Text] [Related]

  • 10. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes.
    Snijdewint FG, Kaliński P, Wierenga EA, Bos JD, Kapsenberg ML.
    J Immunol; 1993 Jun 15; 150(12):5321-9. PubMed ID: 8390534
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism.
    Yu Y, Chadee K.
    J Immunol; 1998 Oct 01; 161(7):3746-52. PubMed ID: 9759900
    [Abstract] [Full Text] [Related]

  • 12. Cyclic AMP synergy with Ca2+ for production of IFN-gamma by a cytolytic T cell clone is post-transcriptional.
    Kaldy P, Schmitt-Verhulst AM.
    J Immunol; 1991 Apr 01; 146(7):2382-7. PubMed ID: 1848581
    [Abstract] [Full Text] [Related]

  • 13. Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels.
    Ishihara K, Ono S, Takahama Y, Hirayama F, Hirano H, Itoh K, Dobashi K, Murakami S, Katoh Y, Yamaguchi M.
    Immunology; 1989 Oct 01; 68(2):154-62. PubMed ID: 2553585
    [Abstract] [Full Text] [Related]

  • 14. Suppression of T-cell responsiveness by inducible cAMP early repressor (ICER).
    Bodor J, Feigenbaum L, Bodorova J, Bare C, Reitz MS, Gress RE.
    J Leukoc Biol; 2001 Jun 01; 69(6):1053-9. PubMed ID: 11404394
    [Abstract] [Full Text] [Related]

  • 15. Sensitivity of IL-5 production to the cAMP-dependent pathway in human T cells is reduced by exogenous IL-2 in a phosphoinositide 3-kinase-dependent way.
    Heijink IH, Kauffman HF, Postma DS, de Monchy JG, Vellenga E.
    Eur J Immunol; 2003 Aug 01; 33(8):2206-15. PubMed ID: 12884295
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E2 suppresses nuclear factor-kappaB mediated interleukin 15 production in rheumatoid synoviocytes.
    Min SY, Kim WU, Cho ML, Hwang SY, Park SH, Cho CS, Kim JM, Kim HY.
    J Rheumatol; 2002 Jul 01; 29(7):1366-76. PubMed ID: 12136890
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-6 attenuates agonist-mediated calcium mobilization in murine osteoblastic cells.
    Green J, Schotland S, Sella Z, Kleeman CR.
    J Clin Invest; 1994 Jun 01; 93(6):2340-50. PubMed ID: 8200968
    [Abstract] [Full Text] [Related]

  • 18. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
    McCahill A, Campbell L, McSorley T, Sood A, Lynch MJ, Li X, Yan C, Baillie GS, Houslay MD.
    Cell Signal; 2008 Nov 01; 20(11):2071-83. PubMed ID: 18721873
    [Abstract] [Full Text] [Related]

  • 19. Alterations in calcium signaling and cellular responses in septic injury.
    Sayeed MM.
    New Horiz; 1996 Feb 01; 4(1):72-86. PubMed ID: 8689277
    [Abstract] [Full Text] [Related]

  • 20. cAMP inhibits the OKT3-induced increase in cytoplasmic free calcium in the Jurkat T cell line: the degree of inhibition correlates inversely with the amount of CD3 binding ligand used.
    Papadogiannakis N, Nordström TE, Andersson LC, Wolff CH.
    Eur J Immunol; 1989 Oct 01; 19(10):1953-6. PubMed ID: 2555197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.